FinTrust Capital Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $239K | Buy |
5,844
+1,341
| +30% | +$54.8K | 0.04% | 279 |
|
|
2024
Q2 | $173K | Buy |
4,503
+18
| +0.4% | +$693 | 0.03% | 307 |
|
|
2024
Q1 | $192K | Sell |
4,485
-912
| -17% | -$39.1K | 0.04% | 290 |
|
|
2023
Q4 | $200K | Buy |
5,397
+1,051
| +24% | +$39K | 0.04% | 273 |
|
|
2023
Q3 | $158K | Buy |
4,346
+281
| +7% | +$10.2K | 0.04% | 287 |
|
|
2023
Q2 | $143K | Hold |
4,065
| – | – | 0.03% | 303 |
|
|
2023
Q1 | $143K | Hold |
4,065
| – | – | 0.03% | 301 |
|
|
2022
Q4 | $143K | Buy |
4,065
+1,647
| +68% | +$57.9K | 0.03% | 301 |
|
|
2022
Q3 | $76K | Sell |
2,418
-504
| -17% | -$15.8K | 0.02% | 430 |
|
|
2022
Q2 | $154K | Sell |
2,922
-985
| -25% | -$51.9K | 0.04% | 304 |
|
|
2022
Q1 | $213K | Sell |
3,907
-130
| -3% | -$7.09K | 0.05% | 275 |
|
|
2021
Q4 | $223K | Buy |
4,037
+943
| +30% | +$52.1K | 0.05% | 269 |
|
|
2021
Q3 | $148K | Sell |
3,094
-187
| -6% | -$8.95K | 0.04% | 322 |
|
|
2021
Q2 | $163K | Buy |
3,281
+471
| +17% | +$23.4K | 0.04% | 313 |
|
|
2021
Q1 | $125K | Sell |
2,810
-118
| -4% | -$5.25K | 0.04% | 358 |
|
|
2020
Q4 | $135K | Sell |
2,928
-216
| -7% | -$9.96K | 0.04% | 321 |
|
|
2020
Q3 | $148 | Sell |
3,144
-629
| -17% | -$30 | 0.03% | 286 |
|
|
2020
Q2 | $192K | Sell |
3,773
-634
| -14% | -$32.3K | 0.08% | 209 |
|
|
2020
Q1 | $209K | Buy |
4,407
+390
| +10% | +$18.5K | 0.1% | 173 |
|
|
2019
Q4 | $236K | Sell |
4,017
-302
| -7% | -$17.7K | 0.1% | 184 |
|
|
2019
Q3 | $230K | Sell |
4,319
-106
| -2% | -$5.65K | 0.08% | 172 |
|
|
2019
Q2 | $221K | Sell |
4,425
-674
| -13% | -$33.7K | 0.09% | 178 |
|
|
2019
Q1 | $266K | Sell |
5,099
-2,068
| -29% | -$108K | 0.11% | 158 |
|
|
2018
Q4 | $343K | Buy |
+7,167
| New | +$343K | 0.17% | 115 |
|